This publication summarises presentations by Dr Angela George, Dr Michelle Wilson and Ms Emma Felix who spoke on mainstreaming genetic testing for ovarian cancer at an AstraZeneca-sponsored Symposium at the New Zealand Society of Oncology (NZSO) Conference in Christchurch in September.
Download PDF